Status:
UNKNOWN
Hypofractionated Radiotherapy Concomitantly With Weekly Boost for Breast Cancer Patients Treated With Conservative Breast Surgery
Lead Sponsor:
Assiut University
Conditions:
Breast Cancer
Eligibility:
All Genders
18-75 years
Brief Summary
This is a retrospective study on evaluation of the efficacy and the safety of a hypofractionated radiotherapy course with weekly concomitant boost for breast cancer patients treated with conservative ...
Eligibility Criteria
Inclusion
- women aged from 18 and up to 55 years old.
- Histologically diagnosed with breast carcinoma (ductal and others )
- All patients with conservative breast surgery.
- Including all patients with in all stages except those stage IV.
- All patients with clear free surgical margin.
- patients received hypofractionated radiotherapy with weekly concomitant boost
Exclusion
- Evidence of distant metastatic deposites.
- patients with mastectomy
- patients with prior irradiation to thoracic region.
- pregnancy or lactation.
Key Trial Info
Start Date :
December 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04815642
Start Date
December 1 2021
End Date
April 1 2023
Last Update
August 3 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.